Clinical trial of mRNA universal influenza vaccine candidate begins
Trial will test the experimental vaccine for safety and its ability to induce an immune response.
Source: National Institutes of Health (NIH) News Releases - Category: American Health Source Type: news
More News: American Health | Clinical Trials | Influenza | Influenza Vaccine | National Institutes of Health (NIH) | Vaccines